Scilex Holding CO 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Scilex Holding Company reports Q1 2026 financial results, highlighting ongoing liquidity challenges, legal disputes, and strategic business combinations.
NASDAQ
Scilex Holding Company reported a significant increase in net losses and negative working capital, raising substantial doubt about its ability to continue as a going concern, while also adopting a new cryptocurrency treasury strategy.
NASDAQ
Scilex Holding Company reports significant net losses and declining revenue across its commercial products, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
10-Q: Scilex Holding Company Reports Q1 2025 Financial Results: Revenue Declines Amid Strategic Shifts
Scilex Holding Company's Q1 2025 revenue decreased due to lower ZTlido sales, while the company continues to manage its debt and explore strategic opportunities.
NASDAQ
10-Q: Scilex Holding Company Reports Q3 2024 Financial Results Amidst Restructuring and Strategic Moves
Scilex Holding Company's Q3 2024 results show a net loss of $4.4 million, with revenue growth offset by increased operating expenses and strategic financial maneuvers.
NASDAQ
Scilex Holding Company's Q2 2024 results show revenue growth driven by ZTlido and ELYXYB, but increased operating expenses and losses.
NASDAQ
Scilex Holding Company's first quarter 2024 results show a net loss of $24.4 million and highlight concerns about the company's ability to continue as a going concern.